Track G

G3 Using the FDA and Patent Overlap to Protect Market Exclusivity *CLE Eligible

Track: IP Trends and Successful Practices

Target Audience: Advanced

Tamsen Valoir, Boulware & Valoir

Margaret Sampson, Baker Botts, LLP

There are few professionals aware of both patent law and US Food and Drug Administration (FD) law, but understanding the overlap between these two areas of law allows one to design the optimal strategy for protecting market exclusivity. Join us for a discussion on the basics of both areas of law, and learn how the two fit together. We will provide exemplary strategies for maximizing protection of different product types.

Return to Schedule

AUTM 2016 Annual Meeting Sponsors